Novel Gene Therapeutic Approaches to Brain Cancer

Maria Castro; James Curtin; Gwendalyn King; Gwendalyn King; Marianela Candolfi; Peter Czer; Sandra A. Sciascia; Kurt Kroeger; Sarah B. Honig; William Kuoy; Terry Kang; Stephen Johnson; Pedro R. Lowenstein

doi:10.21427/e3bq-qp57

Novel Gene Therapeutic Approaches to Brain Cancer

Maria Castro
, James Curtin
, Gwendalyn King
, Gwendalyn King
, Marianela Candolfi
, Peter Czer
, Sandra A. Sciascia
, Kurt Kroeger
, Sarah B. Honig
, William Kuoy
, Terry Kang
, Stephen Johnson
, Pedro R. Lowenstein

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.

Original language	English
Title of host publication	Gene Therapy for Neurological Disorders
Editors	Maria G. Castro, Pedro R. Lowenstein
Place of Publication	New York, NY
Publisher	Taylor & Francis Group, L.L.C.
Chapter	13
ISBN (Print)	978-0-8247-2847-2, 0-8247-2847-5
DOIs	https://doi.org/10.21427/e3bq-qp57
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.21427/e3bq-qp57Licence: CC BY-NC-SA

Cite this

Castro, M., Curtin, J., King, G., King, G., Candolfi, M., Czer, P., Sciascia, S. A., Kroeger, K., Honig, S. B., Kuoy, W., Kang, T., Johnson, S., & Lowenstein, P. R. (2006). Novel Gene Therapeutic Approaches to Brain Cancer. In M. G. Castro, & P. R. Lowenstein (Eds.), Gene Therapy for Neurological Disorders Taylor & Francis Group, L.L.C.. https://doi.org/10.21427/e3bq-qp57

@inbook{677b6f838c514565a43d7f3e09f0fbb8,

title = "Novel Gene Therapeutic Approaches to Brain Cancer",

abstract = "In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.",

author = "Maria Castro and James Curtin and Gwendalyn King and Gwendalyn King and Marianela Candolfi and Peter Czer and Sciascia, \{Sandra A.\} and Kurt Kroeger and Honig, \{Sarah B.\} and William Kuoy and Terry Kang and Stephen Johnson and Lowenstein, \{Pedro R.\}",

year = "2006",

doi = "10.21427/e3bq-qp57",

language = "English",

isbn = "978-0-8247-2847-2",

editor = "Castro, \{Maria G.\} and Lowenstein, \{Pedro R.\}",

booktitle = "Gene Therapy for Neurological Disorders",

publisher = "Taylor \& Francis Group, L.L.C.",

}

TY - CHAP

T1 - Novel Gene Therapeutic Approaches to Brain Cancer

AU - Castro, Maria

AU - Curtin, James

AU - King, Gwendalyn

AU - Candolfi, Marianela

AU - Czer, Peter

AU - Sciascia, Sandra A.

AU - Kroeger, Kurt

AU - Honig, Sarah B.

AU - Kuoy, William

AU - Kang, Terry

AU - Johnson, Stephen

AU - Lowenstein, Pedro R.

PY - 2006

Y1 - 2006

N2 - In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.

AB - In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.

U2 - 10.21427/e3bq-qp57

DO - 10.21427/e3bq-qp57

M3 - Chapter

SN - 978-0-8247-2847-2

SN - 0-8247-2847-5

BT - Gene Therapy for Neurological Disorders

A2 - Castro, Maria G.

A2 - Lowenstein, Pedro R.

PB - Taylor & Francis Group, L.L.C.

CY - New York, NY

ER -

Novel Gene Therapeutic Approaches to Brain Cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this